You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海南海藥(000566.SZ):仍未收到華穗19號信託本金2億元及相關利息
格隆匯 11-02 19:24

格隆匯11月2日丨海南海藥(000566.SZ)公佈,為防範風險,保護公司利益,公司對持有的華穗19號信託採取相關增信措。重慶永通信息工程實業有限公司、重慶賽諾生物藥業股份有限公司、重慶金賽醫藥有限公司、深圳市南方同正投資有限公司及其實際控制人劉悉承等相關方共同向海南海藥承諾承擔連帶清償責任,並承諾於20211031之前償還2億元本金及利息。具體內容詳見公司於2021924披露的相關公吿。

截至公吿披露日,由於重慶金賽醫藥有限公司及上述承諾方資產處置未按照預期完成,重慶金賽醫藥有限公司及上述承諾方未清償債權以致公司仍未收到華穗19號信託本金2元及2021923日之後的利息。

公司已成立專項小組,尋求解決方案,派專人負責此事,跟蹤並督促對方儘快償還欠款,進一步查找債務人資產。同時已向人民法院提起訴訟,以最大程度減少公司的潛在損失,維護公司的合法權益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account